Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?
Read More »Ertugliflozin Proved Effective in Patients with Type 2 Diabetes and ASCVD
A VERTIS CV sub study showed significant improvements in glycemic control after adding ertugliflozin to insulin-based regimens.
Read More »Mental Disorders Complicate the Treatment of Patients with Diabetes
Individuals with mental health disorders have an increased risk for type 2 diabetes and premature death; modifiable risk factors affected by antipsychotics are obesity, insulin resistance, diabetes, and dyslipidemia.
Read More »ADA 2021: Finerenone in the Chronic Kidney Disease and Diabetes Population
Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?
Read More »ADA 2021: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with T2D and Hypertension
Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.
Read More »Gestational Diabetes Can Increase CVD Risk
GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.
Read More »ADA 81st Symposium: Cardiovascular and Kidney Outcomes in Efpeglenatide
With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?
Read More »How are Diabetes and Cardiovascular Disease Related?
Major electrocardiogram abnormalities have been found in patients with type 2 diabetes.
Read More »Effects of Basal Insulin on Lipids vs. Other Antihyperglycemics
How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?
Read More »ADA 2021: Summary for Classification, Prevention, and Treatment of Heart Failure in Patients with Diabetes
American Diabetes Association mini-symposium presented by Biykem Bozkurt, MD, Ph.D., FHFSA, FACC, FAHA, FESC.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.